0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Demyelinating Disorders
 21-40 of 591 Articles
JAMA Neurology | 
Review | 
Erin E. Longbrake, MD, PhD; Anne H. Cross, MD
JAMA Neurol. 2016;73(2):219-225. doi:10.1001/jamaneurol.2015.3977.

JAMA | 
JAMA Clinical Evidence Synopsis | 
Irene Tramacere, PhD; Cinzia Del Giovane, PhD; Graziella Filippini, MD
JAMA. 2016;315(4):409-410. doi:10.1001/jama.2015.18984.

JAMA Neurology | 
Clinical Pathologic Conference | 
Nathan H. Kung, MD; Nancy L. Bartlett, MD; Nabeel R. Yaseen, MD; et al.
JAMA Neurol. 2015;72(12):1519-1523. doi:10.1001/jamaneurol.2015.2390.
Includes: Supplemental Content

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;314(21):2226. doi:10.1001/jama.2015.16086.

JAMA Neurology | 
Review | 
Brian C. Callaghan, MD, MS; Raymond S. Price, MD; Kevin S. Chen, MD; et al.
JAMA Neurol. 2015;72(12):1510-1518. doi:10.1001/jamaneurol.2015.2347.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Nynne Nyboe Andersen, MD; Björn Pasternak, MD, PhD; Mikael Andersson, MSc; et al.
JAMA Intern Med. 2015;175(12):1990-1992. doi:10.1001/jamainternmed.2015.5396.

JAMA Neurology | 
Editorial | 
Dennis Bourdette, MD; Daniel Hartung, PharmD, MPH
JAMA Neurol. 2015;72(12):1411-1413. doi:10.1001/jamaneurol.2015.2605.

JAMA Neurology | 
Original Investigation | 
Serena Ruggieri, MD; Maria Petracca, MD; Aaron Miller, MD; et al.
JAMA Neurol. 2015;72(12):1466-1474. doi:10.1001/jamaneurol.2015.1897.

JAMA Neurology | 
Original Investigation | 
Jeffrey Cohen, MD; Anna Belova, MD; Krzysztof Selmaj, MD; et al.
JAMA Neurol. 2015;72(12):1433-1441. doi:10.1001/jamaneurol.2015.2154.
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Kathryn C. Fitzgerald, ScM; Kassandra L. Munger, ScD; Karl Köchert, MD; et al.
JAMA Neurol. 2015;72(12):1458-1465. doi:10.1001/jamaneurol.2015.2742.
Includes: Supplemental Content

JAMA Neurology | 
Viewpoint | 
Mahboobeh Fereidan-Esfahani; Wolfgang Brück, MD; Martin S. Weber, MD
JAMA Neurol. 2015;72(12):1407-1408. doi:10.1001/jamaneurol.2015.2869.

JAMA Neurology | 
Review | 
Bharath Wootla, PhD; Jens O. Watzlawik, PhD; Arthur E. Warrington, PhD; et al.
JAMA Neurol. 2015;72(11):1346-1353. doi:10.1001/jamaneurol.2015.2188.

JAMA Neurology | 
Research Letter | 
Bardia Nourbakhsh, MD; Nisha Revirajan, MD; Emmanuelle Waubant, MD, PhD
JAMA Neurol. 2015;72(11):1374-1375. doi:10.1001/jamaneurol.2015.2332.

JAMA Neurology | 
Special Communication | 
Michelle Bowman, MD; Michael Racke, MD; John Kissel, MD; et al.
JAMA Neurol. 2015;72(11):1342-1345. doi:10.1001/jamaneurol.2015.1891.

JAMA Neurology | 
Images in Neurology | 
Lia D. Ernst, MD; Kenneth Brock, BA; Luis H. Barraza, MD; et al.
JAMA Neurol. 2015;72(11):1370-1371. doi:10.1001/jamaneurol.2015.2141.

JAMA Neurology | 
Editorial | 
Myla D. Goldman, MD; Olaf Stüve, MD, PhD
JAMA Neurol. 2015;72(10):1105-1106. doi:10.1001/jamaneurol.2015.1805.

JAMA Neurology | 
Original Investigation | 
Ryan Ramanujam, PhD; Anna-Karin Hedström, MD; Ali Manouchehrinia, PhD; et al.
JAMA Neurol. 2015;72(10):1117-1123. doi:10.1001/jamaneurol.2015.1788.
Includes: CME

JAMA Neurology | 
Observation | 
Lutz Achtnichts, MD; Otilia Obreja, MD, PhD; Anna Conen, MD; et al.
JAMA Neurol. 2015;72(10):1203-1205. doi:10.1001/jamaneurol.2015.1746.

JAMA Neurology | 
Images in Neurology | 
Jung E. Park, MD; Katharine Alter, MD; Mark Hallett, MD
JAMA Neurol. 2015;72(10):1196-1197. doi:10.1001/jamaneurol.2015.1456.

JAMA Neurology | 
Original Investigation | 
Kerstin Hellwig, MD; Milena Rockhoff, MD; Sandra Herbstritt, PharmD; et al.
JAMA Neurol. 2015;72(10):. doi:10.1001/jamaneurol.2015.1806.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Perspectives on Safety and Efficacy—The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis
Edward R. Hammond, MD, PhD, MPH
JAMA Neurology
Original Investigation  | 
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study
Ludwig Kappos, MD; David K. B. Li, MD; Olaf Stüve, MD; et al.
JAMA Neurology
Editorial  | 
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis Are There Lessons to Be Learned?
Rhonda Voskuhl, MD
JAMA Neurology
Original Investigation  | 
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
Stacy Ellen Hatcher, BS; Emmanuelle Waubant, MD, PhD; Bardia Nourbakhsh, MD; et al.